[go: up one dir, main page]

WO1999011306A1 - Codage de seringues pour controler leur utilisation - Google Patents

Codage de seringues pour controler leur utilisation Download PDF

Info

Publication number
WO1999011306A1
WO1999011306A1 PCT/NZ1998/000133 NZ9800133W WO9911306A1 WO 1999011306 A1 WO1999011306 A1 WO 1999011306A1 NZ 9800133 W NZ9800133 W NZ 9800133W WO 9911306 A1 WO9911306 A1 WO 9911306A1
Authority
WO
WIPO (PCT)
Prior art keywords
carrier
site
coded
predetermined
verification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NZ1998/000133
Other languages
English (en)
Inventor
Alan Forbes Merry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Safer Sleep Ltd
Original Assignee
Safer Sleep Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Safer Sleep Ltd filed Critical Safer Sleep Ltd
Priority to GB0004689A priority Critical patent/GB2344530B/en
Priority to CA002302590A priority patent/CA2302590C/fr
Priority to NZ503714A priority patent/NZ503714A/xx
Priority to EP98941952A priority patent/EP1009455A4/fr
Priority to AU90106/98A priority patent/AU752495B2/en
Publication of WO1999011306A1 publication Critical patent/WO1999011306A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/008—Racks for supporting syringes or needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B50/00—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers
    • A61B50/30—Containers specially adapted for packaging, protecting, dispensing, collecting or disposing of surgical or diagnostic appliances or instruments
    • A61B50/33—Trays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90—Identification means for patients or instruments, e.g. tags
    • A61B90/92—Identification means for patients or instruments, e.g. tags coded with colour
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90—Identification means for patients or instruments, e.g. tags
    • A61B90/94—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
    • A61B90/96—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text using barcodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90—Identification means for patients or instruments, e.g. tags
    • A61B90/98—Identification means for patients or instruments, e.g. tags using electromagnetic means, e.g. transponders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/10—Bar codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/20—Colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6063—Optical identification systems
    • A61M2205/6081—Colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics

Definitions

  • This invention relates to methods and apparatus for storage, dispensing and use of administrable substances, particularly for anaesthetics. Whilst the invention is primarily directed to anaesthetics, the invention is not limited thereto and may be used in other related areas.
  • a likelihood of errors is also exacerbated by an increasing complexity of drug administration procedures, types of drugs and their subsets, together with often potentially confusing markings, packaging, concentrations and the like which all but the most alert practitioner might otherwise mistake, especially in emergency or other stressful circumstances.
  • a method of monitoring substance administration including the steps of establishing first and second predetermined coded substance sites for a predetermined coded substance carrier, placing said carrier in an at least partially loaded condition prior to use in said first site and after use in an at least partially discharged condition (relative to said at least partially loaded condition) in said second site and maintaining said carrier in said second site for a predetermined period of time.
  • a method of monitoring substance administration including the steps of forming a support device having a first predetermined coded substance site for a predetermined coded loaded substance carrier, forming a second predetermined coded site for such carrier, taking said carrier from said first predetermined site for use and, after use, positioning said carrier in the second site
  • apparatus for storage and use of at least one administrable substance carrier including a support defining at least one coded site in relation to which the predetermined coded carrier can be positioned, said site coded and adapted to receive and a predeterminedly coded, loaded carrier, said code provided to enable user verification of said carrier relative to said at least one site.
  • apparatus for storage and use of at least one administrable substance carrier including a support defining at least one coded site in relation to which the predetermined coded carrier can be positioned, said site provided at least as a set of a first site and a second site, said first site coded and adapted to receive a predeterminedly coded, loaded carrier and a second site at least partially commonly coded and also adapted to receive the carrier, said code provided to enable user verification of said carrier relative to said first and second sites.
  • a package of at least one contained administrable substance for administration in accordance with the method as outline above said package including a support as defined hereinbefore, and wherein at least one of said first sites is charged with a loaded, substantially corresponding coded carrier for said administrable substance and means provided between said carrier and said first coded site for verifying the correct site positioning of said carrier on said site, a second coded site adapted for verification of site position.
  • Figure 1 is a perspective view of an anaesthetic trolley showing the apparatus of the invention mounted therewith.
  • Figure 2 is an alternative embodiment of the tray according to the invention.
  • Figure 3 is an alternative embodiment of the tray according to the invention.
  • the invention is not limited thereto.
  • the invention is applicable in other areas of practice where monitoring of use and a normally predetermined sequence of use is desired.
  • Many anaesthesia practices are carried out according to relatively standard and repeatable steps, although naturally there often are variations. In other words, there is a sequence through which the practitioner often passes during the course of an operation.
  • the anaesthetist would normally administer drugs or medications in types or classes, amounts (usually volumes) and concentrations dependent on, amongst other things, body mass, degree of anaesthesia required, age, blood pressure, specific patient criteria etc., however, the drugs used in the main generally tend to follow certain predetermined sets of procedures.
  • the present invention provides a means of reducing reliance on the above procedures to reduce mistakes.
  • the invention provides a basis for reliance upon sequencing, monitoring and verification, utilising such features as coding, including colour codes, bar codes with comparison against predetermined data and similar techniques and combinations thereof to achieve risk reduction.
  • the present invention provides both a means and apparatus to minimise errors utilising in the preferred form of the invention prefilled colour coded carriers in the form of syringes S (see Figures 2 and 3) .
  • the syringes S will usually be prefilled by a hospital pharmacy or pharmaceutical manufacturer/supplier and be neatly colour coded by class of drug and other details which may be necessary.
  • the colours indicate drug classes rather than individual drugs as a drug error between classes is usually much more dangerous than one within a class.
  • alternative coding can be incorporated including any one or a combination of: colour coding colour combinations pattern codes iv. numeric codes v. alpha codes vi. bar codes
  • colour coding by class will also minimise the total colours used making the classification system simpler. Whilst colour coding is preferred for classes of drugs, in alternative arrangements it will also be appreciated that a combination of drug class/individual drug may also be provided, for example utilising a two-tier code system or some other detectable identifier or combination of identifier.
  • coloured syringe S labels S 1 are used incorporating the name of the drug in bold print of a size that they will wrap around the syringe S barrel in a way that the colour code can be seen from any likely syringe orientation.
  • the syringe body or plunger itself can be colour coded, such as at manufacture.
  • syringe marking scales will be retained and further, different densities or shades of colour on the label may used to indicate the strength or concentration of the drug.
  • syringes S or other dispensing apparatus may be prefilled and supplied by drug companies in a substantially complete state.
  • the code can also hold this information if required.
  • syringes S are provided in conjunction with a drug tray 1 .
  • anaesthetic procedures will be divided into preferably three classes according to factors, such as complexity, for example “minor”, “intermediate” and “major” .
  • Sealed sterile plastic trays 1 will be prepackaged with prefilled coded syringes S of the drug classes needed in the "standard” anaesthetic procedure for each of the three classes, resulting in three classes of drug tray 1 .
  • the tray 1 design preferably incorporates separate sites or compartments 2 each, if required, incorporating individually sealed rip-top covers 3 for each compartment 2.
  • Each compartment 2 is the same coded colour 2c as the prefilled syringe S which that compartment 2 is intended to house either by a suitable label or permanent marking 2c on the compartments.
  • the compartments 2 are preferably arranged in a positionally sensitive manner allowing the syringes S to be used from, for example, left to right across the tray 1 as the anaesthetic procedure proceeds.
  • Each compartment 2 is preferably provided with two subcompartments, a first subcompartment 2a or site, and a second subcompartment 2b or site.
  • the first subcompartment 2a is preferably provided adjacent to a tray front 4 for preloaded, filled syringes S and is designated the "ready" subcompartment 2a.
  • the other, preferably rearward second subcompartments 2b is provided for used or empty syringes S (not shown) and is designated the "used" subcompartment 2b.
  • drug trays 1 in each class will also preferably provide also initially empty compartments 2 (including both empty first and second subcompartments 2a and 2b). These empty compartments 2 are provided for use with drugs which are frequently but not always used and are therefore considered not strictly "standard”.
  • the additional compartments 2 can, for example, be supplied with prefilled syringes S from a standard drug drawer D in the anaesthetists trolley T before starting the anaesthetic procedure.
  • Coding systems and/or labelling will also be used in relation to the additional components 2 by inserting, adhering or otherwise positionally placing both on the syringe S and the additional compartment 2 appropriate codes such as colour codes or other identifier means.
  • a syringe S has been used, if further doses are required these can be obtained by reloading the relevant "ready" subcompartment 2a of the tray 1 with additional prefilled syringes S from a source, perhaps a colour coded drug drawer D elsewhere on the anaesthetists trolley, sympathetically or correspondingly set out and possibly similarly or otherwise coded for ready verification.
  • Used syringes S will accumulate in the relevant "used" subcompartment 2b of the tray 1 as the anaesthetic proceeds and be retained there until the completion of the whole procedure, thus providing ready verification of the identity and amount of drug used at any point in the procedure.
  • a section of the tray 1 for example a righthand section 5 thereof is designed to accommodate drugs only available in ampoules.
  • the coded compartments 2 in this section comprise three subcompartments, a forwardmost compartment 2c for the placement of ampoule A from a colour coded ampoule drawer (not shown) elsewhere in the drug trolley, the middle subcompartment 2e for placement of the syringe S conventionally filled from the ampoule A and colour coded; together with a rearmost compartment 2c for an empty ampoule A (not shown) after the syringe S has been filled.
  • An emergency drug tray of this type may have the greatest potential to reduce drug error since it is during an emergency that errors are most likely to occur.
  • the emergency tray 1 may be stocked or restocked from an emergency "reserve" drug drawer D in a similar way to the standard trays 1 .
  • each syringe S will incorporate some identification means comparable against predetermined data, for example in a prepared database, to positively identify the contained drug, for example by class, individual drug, concentration and other relevant data to the procedure.
  • identification means for example electronically stored and/or readable identification apparatus, magnetic or digital devices, data information and the like.
  • each syringe S may be, for example, "swiped" under a conveniently positioned reader as part of the drug administration routine the detected code will be compared against the database information and drug identified, whereupon a calm computer generated voice will announce the name and dose of the drug just swiped optionally coupled with a visual display.
  • the response will preferably occur at a time anticipated to be before the actual drug administration. It is envisaged that this will considerably reduce the risk of drug error by supplementing the anaesthetist's already received information with further auditory/visual information to hopefully allow correction of any errors before administration.
  • information received by the monitoring apparatus will be conveyed and stored as a record, for example in a microprocessor based device including a database of drug, drug use and patient information loaded thereon. It is anticipated that the practitioner may, on receiving confirmation of the identity of syringe S from the computerised announcement or verification may physically confirm, for example by depressing a "confirm" key, to confirm verification and/or administration, by taking such action either prior to or subsequent to administration of the identified drug. Measuring apparatus can also optionally be provided connected either directly or indirectly with the syringe S to monitor, measure and record amounts of such drug administration, regardless of the syringe S volume as loaded.
  • the monitoring method and apparatus may incorporate a series "standard” or “specific” administrations previously worked out for the anaesthetic procedure.
  • the monitoring apparatus will have such procedures entered into the database and the monitoring apparatus will detect and then compare the removal of syringes S from the "ready" subcompartment 2a of the tray 1 against a predetermined "standard administration order" and not only will provide auditory/visual verification of the syringe S taken, but may also provide an auditory/ visual or other warning to the anaesthetist of any variation from the predetermined routine of administration.
  • the compartments 2 are provided with suitable sensing or detection means 6, for example positioned in the base 7 of each subcompartment 2a/2b.
  • the syringes S are provided with identification means thereon in the form of magnetic/digital devices and others, which can be readily detected by the sensors 6 placed within the base of the tray 1 .
  • the monitoring apparatus is set up to distinguish individual syringes S and drug classes and characteristics in the compartments 2 such that at any stage an accurate and reliable verification of supply, use and countback of drugs/syringes used can be provided and also be monitored against predetermined and anticipated usage manually or via the database as a cross-checking procedure.
  • the upper portion of the trolley T, or some other support apparatus adapted to be used with the tray 1 of this invention may be provided with suitable sensors; the tray 1 being provided of a means substantially inert to interaction between the syringe code and the sensor 6 so as enable simple formation of the trays, or provision of the trays as a liner for separate support apparatus.
  • the cost of tray 1 can be kept to a minimum and further, the sensors/monitoring apparatus will not interfere unduly with necessary sterilisation and other hygiene steps inevitably required.
  • the tray 1 apparatus is provided as a plastics or metal tray 1 able to be sterilised and adapted for ready placement and holding of the syringes S in the required layout for substantially standardised use and providing the first "ready" and the second "used” subcompartments 2a and 2b in a visually separate manner.
  • the drug tray 1 is vacuum formed in a thin sheet plastics material, for example transparent or translucent plastics sheet which is capable of being readily cleansed by heat, irradiation and the like.
  • the tray 1 is preferably arranged in a generally “tapered” configuration so as to be “nestably stackable” with similar trays 1 , such that a "pack" of trays 1 can be supplied for general use.
  • the tray 1 is dimensioned for use with the standard drugs trolley T, substantially as shown in Figure 1 and further the outer peripheral dimensions of the tray 1 are such that preferably a pair of trays 1 according to Figure 3 can be mounted side-by-side on the standard drugs trolley T as is typically used in a theatre or other hospital situation, although such use is not essential.
  • the sites or compartments 2 are positioned on either side of an enlargement 10 upon which a plurality of arcuate rests or syringe sites 1 1 are provided.
  • the syringe sites 1 1 are in this form inclined toward a front 4 of the tray 1 such that syringes S can be readily supported, and viewable by the user.
  • the syringe S after use is able to be positioned in the second compartment 2b which has tapered apertures provided in the second compartment 2b into which a boss B of the syringe S body can optionally frictionally engage, to thus mount the syringe S neatly in a secure and readily visible, verifiable substantially upright manner after use.
  • the syringe sites 1 1 also include a predetermined array (preferably three in respect to each compartment 2 "set") of arcuate rests into which the syringe S can be mounted, inclined forwardly to the user to provide good vision for the user and the syringe S and coding (for example colour coding) at 1 2 on the sites 1 1 , and on the body of the syringe S.
  • a predetermined array preferably three in respect to each compartment 2 "set” of arcuate rests into which the syringe S can be mounted, inclined forwardly to the user to provide good vision for the user and the syringe S and coding (for example colour coding) at 1 2 on the sites 1 1 , and on the body of the syringe S.
  • a supplementary area 1 5 is provided across the front 4 of the tray 1 for incidental items and the like as may be required during the course of the anaesthesia operation.
  • the drugs trolley T can be arranged on it's upper portion thereof with an enlargement over which the tray 4 can fit.
  • coding 1 2 can be positioned either on the trolley T prior to the application of a tray 1 thereover, where the coding 1 2 can be " read” through transparent or translucent portions of the tray 1 , or alternatively, the coding 1 2 can be affixed on an underside of the tray 1 .
  • additional coding 1 2 may be provided substantially corresponding on a front face 1 6 of the enlargement 10 to enable additional simple code 1 2 verification relevant to the particular "row” of the compartments, the syringe sites 1 1 and in the second compartment 2b.
  • the drugs and drugs tray 1 may be stocked in a "package" form, where a recess provided beneath the enlargement 10 is used for storage of the drugs, syringes S and other items to be used in an anaesthesia operation, optionally contained within a tear-off sheet plastics sheet and the like releasably mounted across adjacent portions of an underside of the tray 1 , thus enclosing the items on the underside of the tray 1 which on removal therefrom can be used with the tray 1 in the manner previously described.
  • the stackable nature of the tray in one alternative embodiment enables a convenient "bulk” store of trays 1 to be held (for example in packs of 1 0, 20 and the like) for convenient usage when required.
  • Tray 1 packages can incorporate sets of separate self-adhesive labels or devices holding the codes and for mounting on the tray 1 , on syringes S and vials V or ampoules A for matching purposes.
  • the sets of codings may be arranged for either substantially "standard” use codes or alternatively, for special or specific codes to be provided in special use arrangements.
  • coded labels arranged for the syringes S are provided in a substantially inverted L shaped configuration, to enable positioning along the syringe body and provision of a readily verifiable code together with a bar code (or interactive indicator for a sensor/monitoring apparatus arrangement) yet still leaving a visual "window" for use of syringe volume graduations thereon.
  • the additional monitoring checking and notification systems of the apparatus also provide the ability for users to enter further information including, for example specific patient drug allergies and furthermore, to hold on the database or library standard codes and pharmaceutical details for drugs.
  • This facility enables enhancement of the monitoring and in particular, the warning facility described in relation to the preferred embodiment, whereby should a user attempt to give a drug to which a patient is allergic or at variance with predetermined protocols, a timely warning can be given.
  • the apparatus can verify and record not only drug identity and strength, but also measure the amount of drug actually administered giving the user additional information during the procedure, and also providing a verifiable record subsequently.
  • the code may additionally provide a basis for drug batch identification and to provide raw data and actuation for inventory information, control and drug reordering.
  • the monitoring apparatus may be integrated, preferably via a microprocessor to additionally provide an integrated help facility for pharmaceutical information such as dosages, drug properties and the like.
  • pharmaceutical information such as dosages, drug properties and the like.
  • One such use would be for the database or library of information on commonly used drugs to be accessible by the user who brings a coded syringe S or other coded drug carrier into proximity with the reader or scanner of the monitoring apparatus and, for example operates a specified key or actuation device to access pharmaceutical information on the drug and its properties during the course of the procedure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention comprend un procédé et un appareil consistant à coder, par des couleurs ou d'autres moyens d'identification, des substances à utiliser dans des procédures d'administration, y compris à prévoir un moyen de support (10) présentant des zones (11) codées (12) de manière correspondante pour fournir une référence supplémentaire ou un moyen de confirmation aux utilisateurs de l'invention, ce qui permet de réduire les risques inhérents associés aux procédures d'administration pouvant faire l'objet d'erreurs. Le procédé comprend les étapes de positionnement d'articles codés dans une première position (2a), avant l'utilisation, et de mise en place desdits articles dans une seconde position codée (2b) après utilisation, et notamment les étapes de contrôle et d'enregistrement des étapes d'utilisation en temps réel simultané, de contrôle de confirmation d'utilisation et ensuite de vérification ou d'enregistrement d'utilisation. L'invention comprend également l'étape de comparaison des étapes d'administration selon une procédure, ou d'utilisation des articles codés par rapport à des schémas prédéterminés, notamment la confirmation audible ou sensorielle de l'utilisation ou d'un ensenble d'utilisations prédéterminées, et l'avertissement contre l'utilisation non prédéterminée et par conséquent potentiellement dangereuse.
PCT/NZ1998/000133 1997-09-03 1998-09-03 Codage de seringues pour controler leur utilisation Ceased WO1999011306A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0004689A GB2344530B (en) 1997-09-03 1998-09-03 Coding of syringes to monitor their use
CA002302590A CA2302590C (fr) 1997-09-03 1998-09-03 Codage de seringues pour controler leur utilisation
NZ503714A NZ503714A (en) 1997-09-03 1998-09-03 A coding method and apparatus for the storage and use of anaesthetic drugs
EP98941952A EP1009455A4 (fr) 1997-09-03 1998-09-03 Codage de seringues pour controler leur utilisation
AU90106/98A AU752495B2 (en) 1997-09-03 1998-09-03 Coding of syringes to monitor their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ328668 1997-09-03
NZ32866897 1997-09-03

Publications (1)

Publication Number Publication Date
WO1999011306A1 true WO1999011306A1 (fr) 1999-03-11

Family

ID=19926425

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NZ1998/000133 Ceased WO1999011306A1 (fr) 1997-09-03 1998-09-03 Codage de seringues pour controler leur utilisation

Country Status (5)

Country Link
EP (1) EP1009455A4 (fr)
AU (1) AU752495B2 (fr)
CA (1) CA2302590C (fr)
GB (1) GB2344530B (fr)
WO (1) WO1999011306A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685678B2 (en) 2000-03-22 2004-02-03 Docusys, Inc. Drug delivery and monitoring system
WO2003105927A3 (fr) * 2002-06-12 2004-03-25 Tecpharma Licensing Ag Dispositif d'injection ou de perfusion a aspect superficiel ameliore
WO2005011513A1 (fr) * 2003-07-26 2005-02-10 Robert Simmoteit Element flexible et son utilisation
EP1595561A3 (fr) * 2004-05-13 2005-12-14 Olympus Corporation Seringue ensemble pour cathéter à ballonnet
EP1421378A4 (fr) * 2001-08-31 2006-03-22 Docusys Inc Systeme et procede d'affichage d'informations pharmacologiques
WO2011042754A1 (fr) * 2009-10-09 2011-04-14 Vernacare Limited Plateau
US8140349B2 (en) 2000-11-29 2012-03-20 Merge Emed, Inc. Drug delivery device incorporating a tracking code
WO2016010979A1 (fr) * 2014-07-14 2016-01-21 Bayer Medical Care Inc. Seringue et système d'injection de fluide avec code d'identification indépendant de l'orientation
EP3943135A3 (fr) * 2014-10-14 2022-06-29 Amgen Inc. Dispositif d'injection de médicament avec indicateurs visuels et audibles

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8210351B2 (en) * 2007-04-19 2012-07-03 Tri State Distribution, Inc. Labeling system with multiple designs for prescription containers

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046254A (en) * 1973-09-19 1977-09-06 Kramer Steven G Surgical trays
US4518208A (en) * 1983-05-12 1985-05-21 Marder Herbert B Apparatus and method for dispensing medicine
US4720881A (en) * 1986-09-08 1988-01-26 Meyers William K Anesthesia accessories
EP0270326A2 (fr) * 1986-12-05 1988-06-08 Nalge Company Récipient de stockage
US4915233A (en) * 1988-11-02 1990-04-10 The Regents Of The University Of California Dental anesthesia organizer
US4943939A (en) * 1988-08-29 1990-07-24 Rocklin Hoover Surgical instrument accounting apparatus and method
EP0455862A2 (fr) * 1990-05-10 1991-11-13 Milcare, Inc. Arrangement de verrouillage pour une armoire de pharmacie
US5651775A (en) * 1995-07-12 1997-07-29 Walker; Richard Bradley Medication delivery and monitoring system and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978335A (en) * 1989-09-29 1990-12-18 Medex, Inc. Infusion pump with bar code input to computer
GB2285926A (en) * 1994-01-14 1995-08-02 Pro Med International Corp A colour coded hypodermic syringe
US5850917A (en) * 1996-12-23 1998-12-22 Denton; George D. Syringe dosage tracking device with cooling feature

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046254A (en) * 1973-09-19 1977-09-06 Kramer Steven G Surgical trays
US4518208A (en) * 1983-05-12 1985-05-21 Marder Herbert B Apparatus and method for dispensing medicine
US4720881A (en) * 1986-09-08 1988-01-26 Meyers William K Anesthesia accessories
EP0270326A2 (fr) * 1986-12-05 1988-06-08 Nalge Company Récipient de stockage
US4943939A (en) * 1988-08-29 1990-07-24 Rocklin Hoover Surgical instrument accounting apparatus and method
US4915233A (en) * 1988-11-02 1990-04-10 The Regents Of The University Of California Dental anesthesia organizer
EP0455862A2 (fr) * 1990-05-10 1991-11-13 Milcare, Inc. Arrangement de verrouillage pour une armoire de pharmacie
US5651775A (en) * 1995-07-12 1997-07-29 Walker; Richard Bradley Medication delivery and monitoring system and methods

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685678B2 (en) 2000-03-22 2004-02-03 Docusys, Inc. Drug delivery and monitoring system
US7074209B2 (en) 2000-03-22 2006-07-11 Docusys, Inc. Drug delivery and monitoring system
EP1265659A4 (fr) * 2000-03-22 2006-12-13 Docusys Inc Systeme de distribution et de surveillance de medicament
US8140349B2 (en) 2000-11-29 2012-03-20 Merge Emed, Inc. Drug delivery device incorporating a tracking code
EP1421378A4 (fr) * 2001-08-31 2006-03-22 Docusys Inc Systeme et procede d'affichage d'informations pharmacologiques
WO2003105927A3 (fr) * 2002-06-12 2004-03-25 Tecpharma Licensing Ag Dispositif d'injection ou de perfusion a aspect superficiel ameliore
WO2005011513A1 (fr) * 2003-07-26 2005-02-10 Robert Simmoteit Element flexible et son utilisation
EP1595561A3 (fr) * 2004-05-13 2005-12-14 Olympus Corporation Seringue ensemble pour cathéter à ballonnet
WO2011042754A1 (fr) * 2009-10-09 2011-04-14 Vernacare Limited Plateau
WO2016010979A1 (fr) * 2014-07-14 2016-01-21 Bayer Medical Care Inc. Seringue et système d'injection de fluide avec code d'identification indépendant de l'orientation
EP3943135A3 (fr) * 2014-10-14 2022-06-29 Amgen Inc. Dispositif d'injection de médicament avec indicateurs visuels et audibles
US11633548B2 (en) 2014-10-14 2023-04-25 Amgen Inc. Drug injection device with visual and audio indicators
US12303674B2 (en) 2014-10-14 2025-05-20 Amgen Inc. Drug injection device with visual and audio indicators

Also Published As

Publication number Publication date
CA2302590A1 (fr) 1999-03-11
GB2344530B (en) 2002-05-01
GB0004689D0 (en) 2000-04-19
CA2302590C (fr) 2007-12-11
EP1009455A1 (fr) 2000-06-21
AU752495B2 (en) 2002-09-19
EP1009455A4 (fr) 2002-03-27
AU9010698A (en) 1999-03-22
GB2344530A (en) 2000-06-14

Similar Documents

Publication Publication Date Title
US20050101905A1 (en) Coding of syringes to monitor their use
US9916715B2 (en) Pharmacy medication verification system
US6335907B1 (en) Package with integrated circuit chip embedded therein and system for using same
ES2895667T3 (es) Procedimiento y aparato para monitorizar, documentar y asistir en la formulación manual de medicamentos
US5431299A (en) Medication dispensing and storing system with dispensing modules
JP6195577B2 (ja) 安全性を高めたシリンジおよび安全に薬剤投与するためのコンビネーションキット
US7941949B2 (en) Multi-flag label
US6685227B2 (en) Label, a label system and method
US8403224B2 (en) Apparatus, system and method for tracking drugs during a repackaging and administering process
US6189727B1 (en) Pharmaceutical dispensing arrangement
EP0379795B1 (fr) Système à récipients pour distribuer des prescriptions pharmaceutiques à des usagers ayant une vue ou compréhension médicale diminuée
CA2302590C (fr) Codage de seringues pour controler leur utilisation
US20190161229A1 (en) Apparatus and method for improving safe identification, selection, distribution, and administration of medications and medicaments to patients
US20120000592A1 (en) Label, labeling system and method of labeling for containers for drug products
EP2436361B1 (fr) Dispositif à verrou électromécanique pour la distribution sécurisée de sang ou d'hémocomposants
ES2562953T3 (es) Estación dispensadora de medicamentos
JPS6373961A (ja) 薬剤の保持陳列装置
JP2002092165A (ja) 注射薬準備方法及び注射薬準備確認システム
GB2285926A (en) A colour coded hypodermic syringe
JP2002085522A (ja) 医薬品の包装体
JP2002092182A (ja) 注射薬準備方法及び注射薬準備確認装置
WO2006031227A1 (fr) Systeme d'avertissement pour administration de medicaments
Kuban 11 Labeling Sterile Preparations
HK1226518B (en) Method and apparatus for monitoring, documenting and assisting with the manual compounding of medications
HK1169305A (en) Device with an electromechanical lock for the safe distribution of blood or hemocomponents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 200004689

Country of ref document: GB

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2302590

Country of ref document: CA

Kind code of ref document: A

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 503714

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1998941952

Country of ref document: EP

Ref document number: 90106/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09508499

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1998941952

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 90106/98

Country of ref document: AU